Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sana Biotechnology, Inc. | 10%+ Owner | Common Stock | 12.4M | $68.5M | $5.50 | Feb 8, 2024 | Indirect |
908 Devices Inc. | Director, 10%+ Owner | Common Stock | 5.73M | $36.8M | $6.42 | Jun 12, 2024 | Indirect |
DA32 Life Science Tech Acquisition Corp. | Director, 10%+ Owner | Class A Common Stock | 650K | $6.5M | $10.00 | Jul 28, 2023 | Through DA32 Sponsor LLC |
Quanterix Corp | Director | Common Stock | 131K | $3.53M | $26.91 | Apr 3, 2023 | Direct |
Twist Bioscience Corp | Director | Common Stock | 18K | $659K | $36.59 | Feb 6, 2024 | Direct |
908 Devices Inc. | Director, 10%+ Owner | Common Stock | 13.9K | $89.4K | $6.42 | Jun 12, 2024 | Direct |
Boundless Bio, Inc. | 10%+ Owner | Common Stock | 1.18M | Apr 2, 2024 | Indirect | ||
908 Devices Inc. | Director, 10%+ Owner | Stock Option (option to buy) | 16K | Jun 13, 2024 | Direct | ||
908 Devices Inc. | Director, 10%+ Owner | Restricted Stock Unit | 11.4K | Jun 13, 2024 | Direct | ||
Boundless Bio, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Apr 2, 2024 | Indirect | ||
Boundless Bio, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | Apr 2, 2024 | Indirect | ||
Boundless Bio, Inc. | 10%+ Owner | Series C Convertible Preferred Stock | 0 | Apr 2, 2024 | Indirect | ||
DA32 Life Science Tech Acquisition Corp. | Director, 10%+ Owner | Class A Common Stock | 0 | $10.00 | Jul 28, 2023 | Through ARCH Venture Fund XI, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MASS | 908 Devices Inc. | Jun 12, 2024 | 4 | $0 | 4 | Jun 14, 2024 | Director, 10%+ Owner |
BOLD | Boundless Bio, Inc. | Apr 2, 2024 | 12 | $3.2M | 4 | Apr 4, 2024 | 10%+ Owner |
BOLD | Boundless Bio, Inc. | Mar 27, 2024 | 0 | $0 | 3 | Mar 27, 2024 | 10%+ Owner |
SANA | Sana Biotechnology, Inc. | Feb 8, 2024 | 3 | $10M | 4 | Feb 12, 2024 | 10%+ Owner |
TWST | Twist Bioscience Corp | Feb 6, 2024 | 1 | $0 | 4 | Feb 9, 2024 | Director |
DALS | DA32 Life Science Tech Acquisition Corp. | Jul 28, 2023 | 1 | $0 | 4 | Aug 10, 2023 | Director, 10%+ Owner |
MASS | 908 Devices Inc. | Jun 14, 2023 | 4 | $0 | 4 | Jun 16, 2023 | Director, 10%+ Owner |
QTRX | Quanterix Corp | Apr 3, 2023 | 1 | $13.1K | 4 | Apr 4, 2023 | Director |
TWST | Twist Bioscience Corp | Feb 7, 2023 | 1 | $0 | 4 | Feb 9, 2023 | Director, 10%+ Owner |
QTRX | Quanterix Corp | Jan 3, 2023 | 3 | $13.1K | 4 | Jan 4, 2023 | Director |
QTRX | Quanterix Corp | Oct 3, 2022 | 1 | $13.9K | 4 | Oct 5, 2022 | Director |
QTRX | Quanterix Corp | Jul 1, 2022 | 1 | $15K | 4 | Jul 6, 2022 | Director, 10%+ Owner |
MASS | 908 Devices Inc. | Jun 15, 2022 | 4 | $0 | 4 | Jun 17, 2022 | Director, 10%+ Owner |
QTRX | Quanterix Corp | Apr 1, 2022 | 1 | $15K | 4 | Apr 5, 2022 | Director, 10%+ Owner |
TWST | Twist Bioscience Corp | Feb 8, 2022 | 1 | $0 | 4 | Feb 10, 2022 | Director |
QTRX | Quanterix Corp | Jan 3, 2022 | 9 | $13K | 4 | Jan 5, 2022 | Director, 10%+ Owner |
QTRX | Quanterix Corp | Oct 1, 2021 | 7 | $13K | 4 | Oct 5, 2021 | Director, 10%+ Owner |
TWST | Twist Bioscience Corp | Aug 12, 2021 | 15 | -$4.82M | 4 | Aug 13, 2021 | Director |
DALS | DA32 Life Science Tech Acquisition Corp. | Aug 5, 2021 | 1 | $0 | 4 | Aug 9, 2021 | Director, 10%+ Owner |
DALS | DA32 Life Science Tech Acquisition Corp. | Jul 30, 2021 | 2 | $22.5M | 4 | Aug 3, 2021 | Director, 10%+ Owner |
DALS | DA32 Life Science Tech Acquisition Corp. | Jul 27, 2021 | 0 | $0 | 3 | Jul 27, 2021 | Director, 10%+ Owner |
QTRX | Quanterix Corp | Jul 1, 2021 | 10 | $13K | 4 | Jul 6, 2021 | Director |
MASS | 908 Devices Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director, 10%+ Owner |
QTRX | Quanterix Corp | Apr 1, 2021 | 7 | $13K | 4/A | Jul 6, 2021 | Director |